FAMAR Group announces acquisition of sterile manufacturing site in Homburg, Germany

Contributed by: PR Newswire

Tags

FAMAR

More Like This

PR Newswire associated0

Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites

PR Newswire associated0

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

PR Newswire associated0

Suanfarma unifies its industrial brands in a rebranding initiative under Suanfarma CDMO

PR Newswire associated0

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

Blue Wolf Capital to Create New CDMO Platform

PR Newswire associated0

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site

PR Newswire associated0

SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products

PR Newswire associated0

Quality, Efficiency, and Accuracy Targeted by Rottendorf Pharma GmbH with Adoption of FactoryTalk PharmaSuite® MES from Rockwell Automation